A detailed history of Gimbal Financial transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gimbal Financial holds 3,924 shares of BMY stock, worth $224,962. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,924
Holding current value
$224,962
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$39.66 - $51.75 $155,625 - $203,067
3,924 New
3,924 $208 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gimbal Financial Portfolio

Follow Gimbal Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gimbal Financial, based on Form 13F filings with the SEC.

News

Stay updated on Gimbal Financial with notifications on news.